Ophthalmic solution
AssigneeRohto Pharmaceutical Co., Ltd.
InventorsSachiko Noyori, Noriko Takagi
Life of this patent
Estimating the term…
Abstract
A novel ophthalmic preparation containing menthol together with sodium cromoglycate and an antihistaminic is provided, which alleviates the unpleasant irritating eye-ache induced by sodium cromoglycate at the time of instillation and enhances the prompt antipruritic effect of the antihistaminic to strongly suppress itchiness of eyes immediately after instillation.
Claims20
An ophthalmic preparation comprising sodium cromoglycate, an antihistaminic, and menthol.
An ophthalmic preparation comprising sterile distilled water, 10 mg/ml sodium cromoglycate, 0.15 mg/ml chlorpheniramine maleate, and 0.06 mg/ml l-menthol.
An ophthalmic preparation comprising sterile distilled water, 10 mg/ml sodium cromoglycate, 0.2 mg/ml diphenhydramine hydrochloride, and 0.06 mg/ml l-menthol.
Dependencies are inferred from the claim text.